Topics


High-grade gliomas | Treatment | Targeted therapy






Home > Publications > Topics > High-grade gliomas > Treatment > Targeted therapy






OVERVIEW






ANLOTINIB

APATINIB

AVAPRITINIB








BEVACIZUMAB










CAMRELIZUMAB










DABRAFENIB










FEXAGRATINIB










IPILIMUMAB










LAROTRECTINIB

LENVATINIB









NILOTINIB

NIVOLUMAB









OLAPARIB










SAMOTOLISIB

SM-1

SORAFENIB








TG02










TARG RADIONUCLIDE THERAPY

TERAMEPROCOL

TRAMETINIB








VEMURAFENIB